PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation

BACKGROUND: Allogeneic hematopoietic stem cell transplantation and checkpoint blockade therapy are immune-based therapies that have activity in selected refractory hematologic malignancies. Interest has developed in combining these treatments for high-risk hematologic diseases. However, there is con...

Descripción completa

Detalles Bibliográficos
Autores principales: Godfrey, James, Bishop, Michael R., Syed, Sahr, Hyjek, Elizabeth, Kline, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319147/
https://www.ncbi.nlm.nih.gov/pubmed/28239465
http://dx.doi.org/10.1186/s40425-017-0211-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319147/
https://www.ncbi.nlm.nih.gov/pubmed/28239465
http://dx.doi.org/10.1186/s40425-017-0211-z

Ejemplares similares